Skip to content

About Us
Our Approach
Pipeline
- Overview
- Publications
Clinical Trials
Investors
Contact

About Us
Our Approach
Pipeline
- Overview
- Publications
Clinical Trials
Investors
Contact

PRESS RELEASES

Choose Year
Search Press Releases

Found 214 Results

November 2, 2020

Minerva Neurosciences Reports Third Quarter 2020 Financial Results And Business Updates

October 26, 2020

Minerva Neurosciences to Report Third Quarter 2020 Financial Results and Business Updates on November 2, 2020

September 9, 2020

Minerva Neurosciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference

September 2, 2020

Minerva Neurosciences to Present at Citi’s 15th Annual BioPharma Virtual Conference

August 13, 2020

Minerva Neurosciences to Present at JMP Securities CNS Forum

August 3, 2020

Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates

July 27, 2020

Minerva Neurosciences to Report Second Quarter 2020 Financial Results and Business Updates on August 3, 2020

July 1, 2020

Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)

June 1, 2020

REVISED WEBCAST & CALL INFORMATION: Minerva Neurosciences to Hold Webcast and Call With Key Opinion Leaders to Present Additional Analyses From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia

May 29, 2020

Minerva Neurosciences Announces Results From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia

«...5 678 9...»

Investor Relations Contact

Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy^*

Unsubscribe

Loading...

Minerva Neurosciences, Inc.
1500 District Avenue
Burlington, MA 01803

Company

About Us
Leadership
Board of Directors
Contact

Science

Our Approach
Pipeline
Publications
Clinical Trials

Investors

Investors Overview
News
Events
SEC Filings
Stock Information
Corporate Governance
FAQs

© 2026 Minerva Neurosciences, Inc.

Privacy Policy
Terms of Use
Accessibility Statement
Cookie Policy

Scroll to Top